NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure.
Saved in:
| Title: | NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure. |
|---|---|
| Authors: | Schmitt W; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Rühs H; Quantitative Pharmacology, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Burghaus R; Systems Pharmacology & Medicine, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Diedrich C; Systems Pharmacology & Medicine, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Duwal S; Systems Pharmacology & Medicine, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Eissing T; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Garmann D; Quantitative Pharmacology, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Meyer M; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Ploeger B; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany., Lippert J; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Aug; Vol. 110 (2), pp. 498-507. Date of Electronic Publication: 2021 Mar 27. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33630302 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schmitt+W%22">Schmitt W</searchLink>; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Rühs+H%22">Rühs H</searchLink>; Quantitative Pharmacology, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Burghaus+R%22">Burghaus R</searchLink>; Systems Pharmacology & Medicine, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Diedrich+C%22">Diedrich C</searchLink>; Systems Pharmacology & Medicine, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Duwal+S%22">Duwal S</searchLink>; Systems Pharmacology & Medicine, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Eissing+T%22">Eissing T</searchLink>; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Garmann+D%22">Garmann D</searchLink>; Quantitative Pharmacology, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Meyer+M%22">Meyer M</searchLink>; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Ploeger+B%22">Ploeger B</searchLink>; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Lippert+J%22">Lippert J</searchLink>; Pharmacometrics, Bayer AG - Pharmaceuticals, Wuppertal, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2021 Aug; Vol. 110 (2), pp. 498-507. <i>Date of Electronic Publication: </i>2021 Mar 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Meta-Analysis – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33630302 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.2222 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 498 Titles: – TitleFull: NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schmitt W – PersonEntity: Name: NameFull: Rühs H – PersonEntity: Name: NameFull: Burghaus R – PersonEntity: Name: NameFull: Diedrich C – PersonEntity: Name: NameFull: Duwal S – PersonEntity: Name: NameFull: Eissing T – PersonEntity: Name: NameFull: Garmann D – PersonEntity: Name: NameFull: Meyer M – PersonEntity: Name: NameFull: Ploeger B – PersonEntity: Name: NameFull: Lippert J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2021 Aug Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 110 – Type: issue Value: 2 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |